Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia

This study aims to confirm the initial pharmacogenetic finding observed within the clinical proof-of-concept trial of an enhanced response to treatment with pomaglumetad methionil (LY2140023 monohydrate) in Caucasian schizophrenia patients homozygous for T/T at single nucleotide polymorphism rs73304...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Pers Med
Autores principales: Nisenbaum, Laura K., Downing, AnnCatherine M., Zhao, Fangyi, Millen, Brian A., Munsie, Leanne, Kinon, Bruce J., Adams, David H., Gomez, Juan Carlos, Penny, Michelle Ann
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4810388/
https://ncbi.nlm.nih.gov/pubmed/26861400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm6010009
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares